VIRI · Virios Therapeutics
Acquired Company
Virios Therapeutics was acquired by Wex Pharmaceuticals (an indirect CK Life Sciences subsidiary) in an all-stock transaction to form Dogwood Therapeutics, Inc.; Virios’ stock will cease trading under VIRI and begin trading under DWTX on October 9, 2024.
Market Cap
N/A
52 Wk Range
N/A - N/A
Previous Close
$1.30
Open
$1.31
Volume
83,181
Day Range
$1.24 - $1.34
Enterprise Value
N/A
Cash
N/A
Avg Qtr Burn
N/A
Insider Ownership
N/A
Institutional Own.
N/A
Qtr Updated
N/A